PEO-PPO-PEO tri-block copolymers for gene delivery applications in human regenerative medicine—an overview

International Journal of Molecular Sciences

Volumn 19, Issue 3, 2018, Pages

  Rey Rico, Ana ^a,b   Cucchiarini, Magali ^a  

^a SAARLAND UNIVERSITY   (Germany)

^b UNIVERSITY OF A CORUÑA   (Spain)

Author keywords

Gene transfer; Nonviral vectors; PEO PPO PEO copolymers; Viral vectors

Indexed keywords

ADENO ASSOCIATED VIRUS VECTOR; COPOLYMER; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; GREEN FLUORESCENT PROTEIN; HERPESVIRUS VECTOR; LENTIVIRUS VECTOR; MACROGOL; NANOCARRIER; POLOXAMER; POLY(PROPYLENE OXIDE); TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG; PEO-PPO-PEO; PROPANEDIOL DERIVATIVE;

GENE EXPRESSION; GENE THERAPY; GENE TRANSFER; GENETIC TRANSFECTION; HUMAN; HYDROGEL; MESENCHYMAL STEM CELL; MICELLE; NONHUMAN; REGENERATIVE MEDICINE; REVIEW; STATIC ELECTRICITY; TEMPERATURE; TRANSGENE; VIRAL GENE DELIVERY SYSTEM; CHEMISTRY; DRUG DELIVERY SYSTEM; PROCEDURES;

DRUG DELIVERY SYSTEMS; GENE TRANSFER TECHNIQUES; HUMANS; MICELLES; POLYETHYLENE GLYCOLS; PROPYLENE GLYCOLS; REGENERATIVE MEDICINE;

EID: 85043573785     PISSN: 16616596     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms19030775     Document Type: Review

References (98)

1. Alvarez-Lorenzo, C.; Rey-Rico, A.; Sosnik, A.; Taboada, P.; Concheiro, A. Poloxamine-based nanomaterials for drug delivery. Front. Biosci. 2010, 2, 424–440.
2. Sosnik, A.; Sefton, M.V. Methylation of poloxamine for enhanced cell adhesion. Biomacromolecules 2006, 7, 331–338.
3. Alvarez-Lorenzo, C.; Sosnik, A.; Concheiro, A. Peo-ppo block copolymers for passive micellar targeting and overcoming multidrug resistance in cancer therapy. Curr. Drug Targets 2011, 12, 1112–1130.
4. Cao, Y.; Rodriguez, A.; Vacanti, M.; Ibarra, C.; Arevalo, C.; Vacanti, C.A. Comparative study of the use of poly(glycolic acid), calcium alginate and pluronics in the engineering of autologous porcine cartilage. J. Biomater. Sci. Polym. Ed. 1998, 9, 475–487.
5. Singh-Joy, S.D.; McLain, V.C. Safety assessment of poloxamers 101, 105, 108, 122, 123, 124, 181, 182, 183, 184, 185, 188, 212, 215, 217, 231, 234, 235, 237, 238, 282, 284, 288, 331, 333, 334, 335, 338, 401, 402, 403, and 407, poloxamer 105 benzoate, and poloxamer 182 dibenzoate as used in cosmetics. Int. J. Toxicol. 2008, 27 (Suppl. S2), 93–128.
6. Kabanov, A.V.; Lemieux, P.; Vinogradov, S.; Alakhov, V. Pluronic block copolymers: Novel functional molecules for gene therapy. Adv. Drug Deliv. Rev. 2002, 54, 223–233.
7. Chiappetta, D.A.; Sosnik, A. Poly(ethylene oxide)-poly(propylene oxide) block copolymer micelles as drug delivery agents: Improved hydrosolubility, stability and bioavailability of drugs. Eur. J. Pharm. Biopharm. 2007, 66, 303–317.
8. Oh, K.T.; Bronich, T.K.; Kabanov, A.V. Micellar formulations for drug delivery based on mixtures of hydrophobic and hydrophilic pluronic block copolymers. J. Control. Release 2004, 94, 411–422.
9. Attwood, D.; Zhou, Z.; Booth, C. Poly(ethylene oxide) based copolymers: Solubilisation capacity and gelation. Expert Opin. Drug Deliv. 2007, 4, 533–546.
10. Gonzalez-Lopez, J.; Alvarez-Lorenzo, C.; Taboada, P.; Sosnik, A.; Sandez-Macho, I.; Concheiro, A. Self-associative behavior and drug-solubilizing ability of poloxamine (tetronic) block copolymers. Langmuir 2008, 24, 10688–10697.
11. Alvarez-Lorenzo, C.; Concheiro, A. Intelligent drug delivery systems: Polymeric micelles and hydrogels. Mini Rev. Med. Chem. 2008, 8, 1065–1074.
12. Pec, E.A.; Wout, Z.G.; Johnston, T.P. Biological activity of urease formulated in poloxamer 407 after intraperitoneal injection in the rat. J. Pharm. Sci. 1992, 81, 626–630.
13. Aliabadi, H.M.; Lavasanifar, A. Polymeric micelles for drug delivery. Expert Opin. Drug Deliv. 2006, 3, 139–162.
14. Anderson, R.A. Micelle formation by oxyethylene-oxypropylene polymers. Pharm. Acta Helv. 1972, 47, 304–308.
15. Alexandridis, P.; Hatton, T.A. Poly(ethylene oxide)-poly(propylene oxide)-poly (ethylene oxide) block copolymer surfactants in aqueous solutions and at interfaces: Thermodynamics, structure, dynamics, and modeling. Colloids Surf. A Physicochem. Eng. Asp. 1995, 96, 1–46.
16. Torchilin, V.P. Structure and design of polymeric surfactant-based drug delivery systems. J. Control. Release 2001, 73, 137–172.
17. Bae, Y.H.; Yin, H. Stability issues of polymeric micelles. J. Control. Release 2008, 131, 2–4.
18. Barreiro-Iglesias, R.; Bromberg, L.; Temchenko, M.; Hatton, T.A.; Concheiro, A.; Alvarez-Lorenzo, C. Solubilization and stabilization of camptothecin in micellar solutions of pluronic-g-poly(acrylic acid) copolymers. J. Control. Release 2004, 97, 537–549.
19. Chiappetta, D.A.; Degrossi, J.; Teves, S.; D’Aquino, M.; Bregni, C.; Sosnik, A. Triclosan-loaded poloxamine micelles for enhanced topical antibacterial activity against biofilm. Eur. J. Pharm. Biopharm. 2008, 69, 535–545.
20. Fuentes, I.; Blanco-Fernandez, B.; Alvarado, N.; Leiva, A.; Radic, D.; Alvarez-Lorenzo, C.; Concheiro, A. Encapsulation of antioxidant gallate derivatives in biocompatible poly(epsilon-caprolactone)-b-pluronic-b-poly(epsilon-caprolactone) micelles. Langmuir 2016, 32, 3331–3339.
21. Shi, C.; Zhang, Z.; Shi, J.; Wang, F.; Luan, Y. Co-delivery of docetaxel and chloroquine via peo-ppo-pcl/tpgs micelles for overcoming multidrug resistance. Int. J. Pharm. 2015, 495, 932–939.
22. Habas, J.P.; Pavie, E.; Perreur, C.; Lapp, A.; Peyrelasse, J. Nanostructure in block copolymer solutions: Rheology and small-angle neutron scattering. Phys. Rev. E Stat. Nonlinear Soft Matter. Phys. 2004, 70, 061802.
23. Perreur, C.; Habas, J.P.; Peyrelasse, J.; Francois, J.; Lapp, A. Rheological and small-angle neutron scattering studies of aqueous solutions of branched peo-ppo-peo copolymers. Phys. Rev. E Stat. Nonlinear Soft Matter. Phys. 2001, 63, 031505.
24. Alvarez-Lorenzo, C.; Gonzalez-Lopez, J.; Fernandez-Tarrio, M.; Sandez-Macho, I.; Concheiro, A. Tetronic micellization, gelation and drug solubilization: Influence of ph and ionic strength. Eur. J. Pharm. Biopharm. 2007, 66, 244–252.
25. Rey-Rico, A.; Silva, M.; Couceiro, J.; Concheiro, A.; Alvarez-Lorenzo, C. Osteogenic efficiency of in situ gelling poloxamine systems with and without bone morphogenetic protein-2. Eur. Cells Mater. 2011, 21, 317–340.
26. Del Rosario, C.; Rodriguez-Evora, M.; Reyes, R.; Simoes, S.; Concheiro, A.; Evora, C.; Alvarez-Lorenzo, C.; Delgado, A. Bone critical defect repair with poloxamine-cyclodextrin supramolecular gels. Int. J. Pharm. 2015, 495, 463–473.
27. Miyazaki, S.; Tobiyama, T.; Takada, M.; Attwood, D. Percutaneous absorption of indomethacin from pluronic f127 gels in rats. J. Pharm. Pharmacol. 1995, 47, 455–457.
28. Fernandez-Tarrio, M.; Yanez, F.; Immesoete, K.; Alvarez-Lorenzo, C.; Concheiro, A. Pluronic and tetronic copolymers with polyglycolyzed oils as self-emulsifying drug delivery systems. AAPS PharmSciTech 2008, 9, 471–479.
29. Marcos, X.; Perez-Casas, S.; Llovo, J.; Concheiro, A.; Alvarez-Lorenzo, C. Poloxamer-hydroxyethyl cellulose-alpha-cyclodextrin supramolecular gels for sustained release of griseofulvin. Int. J. Pharm. 2016, 500, 11–19.
30. Kolesky, D.B.; Truby, R.L.; Gladman, A.S.; Busbee, T.A.; Homan, K.A.; Lewis, J.A. 3D bioprinting of vascularized, heterogeneous cell-laden tissue constructs. Adv. Mater. 2014, 26, 3124–3130.
31. Chang, C.C.; Boland, E.D.; Williams, S.K.; Hoying, J.B. Direct-write bioprinting three-dimensional biohybrid systems for future regenerative therapies. J. Biomed. Mater. Res. B Appl. Biomater. 2011, 98, 160–170.
32. Kabanov, A.V.; Chekhonin, V.P.; Alakhov, V.; Batrakova, E.V.; Lebedev, A.S.; Melik-Nubarov, N.S.; Arzhakov, S.A.; Levashov, A.V.; Morozov, G.V.; Severin, E.S., et al. The neuroleptic activity of haloperidol increases after its solubilization in surfactant micelles. Micelles as microcontainers for drug targeting. FEBS Lett. 1989, 258, 343–345.
33. Zhang, T.; Zhou, S.; Liu, Y.; Luo, X.; Di, D.; Song, Y.; Liu, X.; Deng, Y. Polysialic acid and pluronic f127 mixed polymeric micelles of docetaxel as new approach for enhanced antitumor efficacy. Drug Dev. Ind. Pharm. 2017, 43, 1827–1835.
34. Zhang, S.S.; Xia, W.T.; Xu, J.; Xu, H.L.; Lu, C.T.; Zhao, Y.Z.; Wu, X.Q. Three-dimensional structure micelles of heparin-poloxamer improve the therapeutic effect of 17beta-estradiol on endometrial regeneration for intrauterine adhesions in a rat model. Int. J. Nanomed. 2017, 12, 5643–5657.
35. Cagel, M.; Bernabeu, E.; Gonzalez, L.; Lagomarsino, E.; Zubillaga, M.; Moretton, M.A.; Chiappetta, D.A. Mixed micelles for encapsulation of doxorubicin with enhanced in vitro cytotoxicity on breast and ovarian cancer cell lines versus doxil((r)). Biomed. Pharmacother. 2017, 95, 894–903.
36. Grimaudo, M.A.; Pescina, S.; Padula, C.; Santi, P.; Concheiro, A.; Alvarez-Lorenzo, C.; Nicoli, S. Poloxamer 407/tpgs mixed micelles as promising carriers for cyclosporine ocular delivery. Mol. Pharm. 2018, 15, 571–584.
37. Bodratti, A.M.; Alexandridis, P. Formulation of poloxamers for drug delivery. J. Funct. Biomater. 2018, 9, 11.
38. Chiappetta, D.A.; Hocht, C.; Taira, C.; Sosnik, A. Efavirenz-loaded polymeric micelles for pediatric anti-hiv pharmacotherapy with significantly higher oral bioavailability [corrected]. Nanomedicine 2010, 5, 11–23.
39. Modi, S.; Prakash Jain, J.; Domb, A.J.; Kumar, N. Exploiting epr in polymer drug conjugate delivery for tumor targeting. Curr. Pharm. Des. 2006, 12, 4785–4796.
40. Harada, A.; Togawa, H.; Kataoka, K. Physicochemical properties and nuclease resistance of antisense-oligodeoxynucleotides entrapped in the core of polyion complex micelles composed of poly(ethylene glycol)-poly(l-lysine) block copolymers. Eur. J. Pharm. Sci. 2001, 13, 35–42.
41. Kwon, G.S. Polymeric micelles for delivery of poorly water-soluble compounds. Crit. Rev. Ther. Drug Carr. Syst. 2003, 20, 357–403.
42. Husseini, G.A.; Myrup, G.D.; Pitt, W.G.; Christensen, D.A.; Rapoport, N.Y. Factors affecting acoustically triggered release of drugs from polymeric micelles. J. Control. Release 2000, 69, 43–52.
43. Fan, W.; Zhang, L.; Li, Y.; Wu, H. Recent progress of crosslinking strategies for polymeric micelles with enhanced drug delivery in cancer therapy. Curr. Med. Chem. 2017.
44. Wang, J.; Li, Y.; Wang, L.; Wang, X.; Tu, P. Comparison of hyaluronic acid-based micelles and polyethylene glycol-based micelles on reversal of multidrug resistance and enhanced anticancer efficacy in vitro and in vivo. Drug Deliv. 2018, 25, 330–340.
45. Nicolaides, N.C.; Sass, P.M.; Grasso, L. Advances in targeted therapeutic agents. Expert Opin. Drug Discov. 2010, 5, 1123–1140.
46. Rey-Rico, A.; Cucchiarini, M. Controlled release strategies for raav-mediated gene delivery. Acta Biomater. 2016, 29, 1–10.
47. Niidome, T.; Huang, L. Gene therapy progress and prospects: Nonviral vectors. Gene Ther. 2002, 9, 1647–1652.
48. Rey-Rico, A.; Cucchiarini, M. Recent tissue engineering-based advances for effective raav-mediated gene transfer in the musculoskeletal system. Bioengineered 2016, 7, 175–188.
49. Breyer, B.; Jiang, W.; Cheng, H.; Zhou, L.; Paul, R.; Feng, T.; He, T.C. Adenoviral vector-mediated gene transfer for human gene therapy. Curr. Gene Ther. 2001, 1, 149–162.
50. Chang, L.J.; Gay, E.E. The molecular genetics of lentiviral vectors—Current and future perspectives. Curr. Gene Ther. 2001, 1, 237–251.
51. Yi, Y.; Noh, M.J.; Lee, K.H. Current advances in retroviral gene therapy. Curr. Gene Ther. 2011, 11, 218–228.
52. Lachmann, R. Herpes simplex virus-based vectors. Int. J. Exp. Pathol. 2004, 85, 177–190.
53. Daya, S.; Berns, K.I. Gene therapy using adeno-associated virus vectors. Clin. Microbiol. Rev. 2008, 21, 583–593.
54. Ibraheem, D.; Elaissari, A.; Fessi, H. Gene therapy and DNA delivery systems. Int. J. Pharm. 2014, 459, 70–83.
55. De Laporte, L.; Cruz Rea, J.; Shea, L.D. Design of modular non-viral gene therapy vectors. Biomaterials 2006, 27, 947–954.
56. Wang, W.; Li, W.; Ma, N.; Steinhoff, G. Non-viral gene delivery methods. Curr. Pharm. Biotechnol. 2013, 14, 46–60.
57. Mumper, R.J.; Duguid, J.G.; Anwer, K.; Barron, M.K.; Nitta, H.; Rolland, A.P. Polyvinyl derivatives as novel interactive polymers for controlled gene delivery to muscle. Pharm. Res. 1996, 13, 701–709.
58. Lemieux, P.; Guerin, N.; Paradis, G.; Proulx, R.; Chistyakova, L.; Kabanov, A.; Alakhov, V. A combination of poloxamers increases gene expression of plasmid DNA in skeletal muscle. Gene Ther. 2000, 7, 986–991.
59. Kabanov, A.V.; Alakhov, V.Y. Pluronic block copolymers in drug delivery: From micellar nanocontainers to biological response modifiers. Crit. Rev. Ther. Drug Carr. Syst. 2002, 19, 1–72.
60. Sriadibhatla, S.; Yang, Z.; Gebhart, C.; Alakhov, V.Y.; Kabanov, A. Transcriptional activation of gene expression by pluronic block copolymers in stably and transiently transfected cells. Mol. Ther. 2006, 13, 804–813.
61. Liu, F.; Yang, J.; Huang, L.; Liu, D. Effect of non-ionic surfactants on the formation of DNA/emulsion complexes and emulsion-mediated gene transfer. Pharm. Res. 1996, 13, 1642–1646.
62. Liaw, J.; Chang, S.F.; Hsiao, F.C. In vivo gene delivery into ocular tissues by eye drops of poly(ethylene oxide)-poly(propylene oxide)-poly(ethylene oxide) (peo-ppo-peo) polymeric micelles. Gene Ther. 2001, 8, 999–1004.
63. Pitard, B.; Pollard, H.; Agbulut, O.; Lambert, O.; Vilquin, J.T.; Cherel, Y.; Abadie, J.; Samuel, J.L.; Rigaud, J.L.; Menoret, S., et al. A nonionic amphiphile agent promotes gene delivery in vivo to skeletal and cardiac muscles. Hum. Gene Ther. 2002, 13, 1767–1775.
64. Riera, M.; Chillon, M.; Aran, J.M.; Cruzado, J.M.; Torras, J.; Grinyo, J.M.; Fillat, C. Intramuscular sp1017-formulated DNA electrotransfer enhances transgene expression and distributes hhgf to different rat tissues. J. Gene Med. 2004, 6, 111–118.
65. Astafieva, I.; Maksimova, I.; Lukanidin, E.; Alakhov, V.; Kabanov, A. Enhancement of the polycation-mediated DNA uptake and cell transfection with pluronic p85 block copolymer. FEBS Lett. 1996, 389, 278–280.
66. Nguyen, H.K.; Lemieux, P.; Vinogradov, S.V.; Gebhart, C.L.; Guerin, N.; Paradis, G.; Bronich, T.K.; Alakhov, V.Y.; Kabanov, A.V. Evaluation of polyether-polyethyleneimine graft copolymers as gene transfer agents. Gene Ther. 2000, 7, 126–138.
67. Gebhart, C.L.; Sriadibhatla, S.; Vinogradov, S.; Lemieux, P.; Alakhov, V.; Kabanov, A.V. Design and formulation of polyplexes based on pluronic-polyethyleneimine conjugates for gene transfer. Bioconjug. Chem. 2002, 13, 937–944.
68. Kuo, J.H. Effect of pluronic-block copolymers on the reduction of serum-mediated inhibition of gene transfer of polyethyleneimine-DNA complexes. Biotechnol. Appl. Biochem. 2003, 37, 267–271.
69. Jeon, E.; Kim, H.D.; Kim, J.S. Pluronic-grafted poly-(l)-lysine as a new synthetic gene carrier. J. Biomed. Mater. Res. A 2003, 66, 854–859.
70. March, K.L.; Madison, J.E.; Trapnell, B.C. Pharmacokinetics of adenoviral vector-mediated gene delivery to vascular smooth muscle cells: Modulation by poloxamer 407 and implications for cardiovascular gene therapy. Hum. Gene Ther. 1995, 6, 41–53.
71. Feldman, L.J.; Pastore, C.J.; Aubailly, N.; Kearney, M.; Chen, D.; Perricaudet, M.; Steg, P.G.; Isner, J.M. Improved efficiency of arterial gene transfer by use of poloxamer 407 as a vehicle for adenoviral vectors. Gene Ther. 1997, 4, 189–198.
72. Van Belle, E.; Maillard, L.; Rivard, A.; Fabre, J.E.; Couffinhal, T.; Kearney, M.; Branellec, D.; Feldman, L.J.; Walsh, K.; Isner, J.M. Effects of poloxamer 407 on transfection time and percutaneous adenovirus-mediated gene transfer in native and stented vessels. Hum. Gene Ther. 1998, 9, 1013–1024.
73. Maillard, L.; Van Belle, E.; Tio, F.O.; Rivard, A.; Kearney, M.; Branellec, D.; Steg, P.G.; Isner, J.M.; Walsh, K. Effect of percutaneous adenovirus-mediated gax gene delivery to the arterial wall in double-injured atheromatous stented rabbit iliac arteries. Gene Ther. 2000, 7, 1353–1361.
74. Wang, Y.; Liu, S.; Li, C.Y.; Yuan, F. A novel method for viral gene delivery in solid tumors. Cancer Res. 2005, 65, 7541–7545.
75. Strappe, P.M.; Hampton, D.W.; Cachon-Gonzalez, B.; Fawcett, J.W.; Lever, A. Delivery of a lentiviral vector in a pluronic f127 gel to cells of the central nervous system. Eur. J. Pharm. Biopharm. 2005, 61, 126–133.
76. Hofig, I.; Atkinson, M.J.; Mall, S.; Krackhardt, A.M.; Thirion, C.; Anastasov, N. Poloxamer synperonic f108 improves cellular transduction with lentiviral vectors. J. Gene Med. 2012, 14, 549–560.
77. Driessens, G.; Nuttin, L.; Gras, A.; Maetens, J.; Mievis, S.; Schoore, M.; Velu, T.; Tenenbaum, L.; Preat, V.; Bruyns, C. Development of a successful antitumor therapeutic model combining in vivo dendritic cell vaccination with tumor irradiation and intratumoral gm-csf delivery. Cancer Immunol. Immunother. 2011, 60, 273–281.
78. Zhang, F.L.; Jia, S.Q.; Zheng, S.P.; Ding, W. Celastrol enhances aav1-mediated gene expression in mice adipose tissues. Gene Ther. 2011, 18, 128–134.
79. Rey-Rico, A.; Venkatesan, J.K.; Frisch, J.; Rial-Hermida, I.; Schmitt, G.; Concheiro, A.; Madry, H.; Alvarez-Lorenzo, C.; Cucchiarini, M. Peo-ppo-peo micelles as effective raav-mediated gene delivery systems to target human mesenchymal stem cells without altering their differentiation potency. Acta Biomater. 2015, 27, 42–52.
80. Diaz-Rodriguez, P.; Rey-Rico, A.; Madry, H.; Landin, M.; Cucchiarini, M. Effective genetic modification and differentiation of hmscs upon controlled release of raav vectors using alginate/poloxamer composite systems. Int. J. Pharm. 2015, 496, 614–626.
81. Rey-Rico, A.; Frisch, J.; Venkatesan, J.K.; Schmitt, G.; Rial-Hermida, I.; Taboada, P.; Concheiro, A.; Madry, H.; Alvarez-Lorenzo, C.; Cucchiarini, M. Peo-ppo-peo carriers for raav-mediated transduction of human articular chondrocytes in vitro and in a human osteochondral defect model. ACS Appl. Mater. Interfaces 2016, 8, 20600–20613.
82. Rey-Rico, A.; Venkatesan, J.K.; Schmitt, G.; Concheiro, A.; Madry, H.; Alvarez-Lorenzo, C.; Cucchiarini, M. Raav-mediated overexpression of tgf-beta via vector delivery in polymeric micelles stimulates the biological and reparative activities of human articular chondrocytes in vitro and in a human osteochondral defect model. Int. J. Nanomed. 2017, 12, 6985–6996.
83. Lu, Q.L.; Bou-Gharios, G.; Partridge, T.A. Non-viral gene delivery in skeletal muscle: A protein factory. Gene Ther. 2003, 10, 131–142.
84. Wolff, J.A.; Malone, R.W.; Williams, P.; Chong, W.; Acsadi, G.; Jani, A.; Felgner, P.L. Direct gene transfer into mouse muscle in vivo. Science 1990, 247, 1465–1468.
85. Kabanov, A.V.; Kabanov, V.A. DNA complexes with polycations for the delivery of genetic material into cells. Bioconjug. Chem. 1995, 6, 7–20.
86. Ramamoorth, M.; Narvekar, A. Non viral vectors in gene therapy—An overview. J. Clin. Diagn. Res. 2015, 9, GE01-06.
87. Chattoraj, D.K.; Gosule, L.C.; Schellman, A. DNA condensation with polyamines. II. Electron microscopic studies. J. Mol. Biol. 1978, 121, 327–337.
88. Zhang, J.; Sen, A.; Cho, E.; Lee, J.S.; Webb, K. Poloxamine/fibrin hybrid hydrogels for non-viral gene delivery. J. Tissue Eng. Regen. Med. 2017, 11, 246–255.
89. Evans, C.H.; Ghivizzani, S.C.; Robbins, P.D. Progress and prospects: Genetic treatments for disorders of bones and joints. Gene Ther. 2009, 16, 944–952.
90. Rey-Rico, A.; Cucchiarini, M. Smart and controllable raav gene delivery carriers in progenitor cells for human musculoskeletal regenerative medicine with a focus on the articular cartilage. Curr. Gene Ther. 2017, 17, 127–138.
91. Jang, J.H.; Houchin, T.L.; Shea, L.D. Gene delivery from polymer scaffolds for tissue engineering. Expert Rev. Med. Devices 2004, 1, 127–138.
92. Rey-Rico, A.; Babicz, H.; Madry, H.; Concheiro, A.; Alvarez-Lorenzo, C.; Cucchiarini, M. Supramolecular polypseudorotaxane gels for controlled delivery of raav vectors in human mesenchymal stem cells for regenerative medicine. Int. J. Pharm. 2017, 531, 492–503.
93. Alakhov, V.Y.; Kabanov, A.V. Block copolymeric biotransport carriers as versatile vehicles for drug delivery. Expert Opin. Investig. Drugs 1998, 7, 1453–1473.
94. Hartikka, J.; Sukhu, L.; Buchner, C.; Hazard, D.; Bozoukova, V.; Margalith, M.; Nishioka, W.K.; Wheeler, C.J.; Manthorp, M.; Sawdey, M. Electroporation-facilitated delivery of plasmid DNA in skeletal muscle: Plasmid dependence of muscle damage and effect of poloxamer 188. Mol. Ther. 2001, 4, 407–415.
95. Li, Z.; Guan, J. Thermosensitive hydrogels for drug delivery. Expert Opin. Drug Deliv. 2011, 8, 991–1007.
96. Lee, J.B.; Yoon, J.J.; Lee, D.S.; Park, T.G. Photo-crosslinkable, thermo-sensitive and biodegradable pluronic hydrogels for sustained release of protein. J. Biomater. Sci. Polym. Ed. 2004, 15, 1571–1583.
97. Grossman, P.M.; Mendelsohn, F.; Henry, T.D.; Hermiller, J.B.; Litt, M.; Saucedo, J.F.; Weiss, R.J.; Kandzari, D.E.; Kleiman, N.; Anderson, R.D., et al. Results from a phase II multicenter, double-blind placebo-controlled study of del-1 (vlts-589) for intermittent claudication in subjects with peripheral arterial disease. Am. Heart J. 2007, 153, 874–880.
98. Wloch, M.K.; Smith, L.R.; Boutsaboualoy, S.; Reyes, L.; Han, C.; Kehler, J.; Smith, H.D.; Selk, L.; Nakamura, R.; Brown, J.M., et al. Safety and immunogenicity of a bivalent cytomegalovirus DNA vaccine in healthy adult subjects. J. Infect. Dis. 2008, 197, 1634–1642.